The global enteric disease testing market was valued at US$ 3.8 Bn in 2022 and is anticipated to expand at a CAGR of 3.3% from 2022 to 2023.
The global enteric disease testing market was valued at US$ 3.8 Bn in 2022 and is anticipated to expand at a CAGR of 3.3% from 2022 to 2023
Untapped market in developing countries: Key Drivers
Various epidemiological sources including WHO, CDC, and NCBI indicate that developing countries account for nearly 85% of the total incidence of enteric diseases. However, a large population suffering from various enteric diseases have no access to basic diagnostic facilities due to lack of awareness, inadequate laboratory settings, and poor economic conditions in these regions.
Download Sample @ https://qyresearchmedical.com/sample/111570
Inexpensive and user-friendly rapid dipstick tests are expected to witness a significant growth during the forecast period as these do not require a laboratory setting for diagnosis and can be performed by patients themselves
The market in relatively better economic countries such as India, China, Mexico, and Brazil could experience a rise in demand for newer technology based laboratory tests such as EIA and PCR tests
Demand for early disease diagnosis Boost Market Growth
The global burden of enteric diseases infection can result into serious health care burden and can even cause deaths. Typhoid salmonellosis, one of the enteric diseases alone accounts for 16 million new cases and approximately 600,000 deaths each year. Early detection of enteric diseases is the only way to cope with this burden.
Traditional culture methods being labor intensive and time consuming are being replaced by tests able to diagnose illness rapidly such as enzyme immunoassay (EIA), PCR based tests, and dipstick based tests
Increasing demand for rapid diagnostic tests is one of the major factors driving the enteric disease testing market
High cost associated with molecular diagnostics assay to Hamper Market
Molecular diagnostic techniques such as multiplexed assay are new in health care as compared to singleplex assays. Hence, multiplexed assay equipment are relatively expensive. The cost per multiplexed assay test is less as compared to singleplex assay test; however, the initial investment for instrument installation is higher.
Considering the initial investment and maintenance cost, larger health care organizations and research institutes can easily afford multiplex diagnostic instruments. On the other hand, purchasing multiplexed assay instrument is difficult for smaller health care organizations and institutes. This restrains the adoption of molecular diagnostic products for enteric disease testing.
Moreover, high cost associated with this technology hampers market growth, especially in the developing nations. Therefore, high cost of the technology is expected to be a major restraint until local entities introduce similar technologies at lower cost.
Global Enteric disease testing Market: Competitive Landscape
This report profiles major players in the global enteric disease testing market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global enteric disease testing market is highly fragmented, with the presence of a number of international as well as regional players
Leading players operating in the global enteric disease testing market are
- Meridian Bioscience, Inc.
- Bio-Rad Laboratories, Inc.
- Alere, Inc.
- bioMérieux SA
- Trinity Biotech plc
- DiaSorin S.p.A.
- Quest Diagnostics
- Coris BioConcept
- TECHLAB, Inc.
- Pro-Lab Diagnostics, Inc.
- Biomerica, Inc.
- Becton Dickinson & Company
- Cepheid Inc.
- among others.
Global Enteric disease testing Market: Key Developments
Key players in the global enteric disease testing market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global enteric disease testing market. A few expansion strategies adopted by players operating in the global enteric disease testing market are:
In July 2017, Meridian Bioscience expanded its business by opening Meridian Bioscience Beijing, LLC, a wholly foreign owned enterprise (WFOE) in Beijing, China.
The report on the global enteric disease testing market discussed individual strategies, followed by company profiles of manufacturers of enteric disease testing. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global enteric disease testing market.
Key Questions Answered in Global Enteric Disease Testing Market Report
- What is the scope of growth of product companies in the global Enteric Disease Testing market?
- What will be the Y-o-Y growth of the global Enteric Disease Testing market between 2019 and 2027?
- What is the influence of changing trends in technologies on the global Enteric Disease Testing market?
- Will North America continue to be the most profitable market for Enteric Disease Testing providers?
- Which factors are anticipated to hamper the growth of the global Enteric Disease Testing market during the forecast period?
- Which are the leading companies in the global Enteric Disease Testing market?
Global Enteric Disease Testing Market – Segmentation
Disease Indication
- Bacterial Enteric Disease
- C.difficile Infection
- Campylobacteriosis
- Cholera
- E.coli Infection
- H.pylori Infection
- Salmonellosis
- Shigellosis
- Viral Enteric Disease
- Rotavirus Infection
- Norovirus Infection
- Parasitic Enteric Disease
- Amebiasis
- Cryptosporidiosis
- Giardiasis
Testing Methods
- Immunoassay Testing
- Conventional Testing
- Molecular Diagnostic Testing
End-user
- Hospitals
- Diagnostic Laboratories
- Physician Offices
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/111570/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/